At a glance
ClinicalIndex Comparison RecordN/ACompleted· 273 enrolled
Drug / intervention
New Dermal Filler +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Controlled, Evaluator-Blinded, Multi-Center Study to Evaluate the Effectiveness and Safety of Restylane Kysse Versus a Control in the Augmentation of Soft Tissue Fullness of the Lip
In Brief
A clinical study evaluating New Dermal Filler and Device: FDA Approved Dermal Filler for Lip Augmentation. Completed, enrolled 273 participants across 14 sites.
Detailed Summary
To demonstrate non-inferiority of Kysse versus a control in lip fullness augmentation
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLip Augmentation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 2017
Enrollment StartNov 2017
Primary CompletionJun 2018
Study CompletionApr 2019
TodayJul 2026
First PostedOct 25, 2017
Enrollment StartNov 13, 2017
Primary CompletionJun 28, 2018
Study CompletionApr 23, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 8.7 years ago
Interventions
New Dermal Fillerdevice
hyaluronic acid
Device: FDA Approved Dermal Fillerdevice
hyaluronic acid